|
Volumn 180, Issue 3, 2004, Pages 179-180
|
Is recombinant Human Erythropoietin Therapy Disadvantageous in Head and Neck Cancer Patients under Radiotherapy?;Verschlechtert die Gabe von rekombinantem humanem Erythropoietin die Prognose von Patienten mit Kopf-Hals-Tumoren unter Radiotherapie?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FERROUS GLUCONATE;
IRON SACCHARATE;
PLACEBO;
RECOMBINANT ERYTHROPOIETIN;
CANCER CONTROL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
HEAD AND NECK CANCER;
HEMOGLOBIN DETERMINATION;
HUMAN;
MAJOR CLINICAL STUDY;
NOTE;
OXYGEN CONCENTRATION;
OXYGENATION;
RADIOSURGERY;
RANDOMIZED CONTROLLED TRIAL;
|
EID: 1542319902
PISSN: 01797158
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (1)
|
References (8)
|